The University of Chicago Header Logo

Connection

Ted Skolarus to Prostate-Specific Antigen

Back to Details
This is a "connection" page, showing publications Ted Skolarus has written about Prostate-Specific Antigen.
Ted Skolarus
Connection Strength
3.392
Prostate-Specific Antigen
  1. Better Understanding the Timing Of Androgen Deprivation Trial Outcomes: Impacts of Prior Androgen Deprivation Therapy. JNCI Cancer Spectr. 2022 05 02; 6(3).
    View in: PubMed
    Score: 0.689
  2. Association between PSA values and surveillance quality after prostate cancer surgery. Cancer Med. 2019 12; 8(18):7903-7912.
    View in: PubMed
    Score: 0.580
  3. The effect of body mass index on PSA levels and the development, screening and treatment of prostate cancer. Nat Clin Pract Urol. 2007 Nov; 4(11):605-14.
    View in: PubMed
    Score: 0.252
  4. Survival by first-line therapy and prognostic group among men with metastatic castration-resistant prostate cancer. Cancer Med. 2024 Jun; 13(12):e7334.
    View in: PubMed
    Score: 0.199
  5. National Long-term Survival Estimates After Radical Prostatectomy for Prostate Cancer. Urology. 2024 02; 184:135-141.
    View in: PubMed
    Score: 0.192
  6. Outcomes after definitive radiation therapy for localized prostate cancer in a national health care delivery system. Cancer. 2023 10 15; 129(20):3326-3333.
    View in: PubMed
    Score: 0.187
  7. Exploring Variation in the Receipt of Recommended Active Surveillance for Men with Favorable-Risk Prostate Cancer. J Urol. 2022 09; 208(3):600-608.
    View in: PubMed
    Score: 0.172
  8. Factors influencing treatment of veterans with advanced prostate cancer. Cancer. 2021 07 01; 127(13):2311-2318.
    View in: PubMed
    Score: 0.160
  9. Characterising potential bone scan overuse amongst men treated with radical prostatectomy. BJU Int. 2019 07; 124(1):55-61.
    View in: PubMed
    Score: 0.135
  10. The Research Implications of Prostate Specific Antigen Registry Errors: Data from the Veterans Health Administration. J Urol. 2018 09; 200(3):541-548.
    View in: PubMed
    Score: 0.130
  11. Accuracy of Prostate-Specific Antigen Values in Prostate Cancer Registries. J Clin Oncol. 2016 10 10; 34(29):3586-3587.
    View in: PubMed
    Score: 0.117
  12. Limitations of Prostate-specific Antigen Testing After a Prostate Cancer Diagnosis. Eur Urol. 2016 08; 70(2):209-10.
    View in: PubMed
    Score: 0.111
  13. Expectant management of veterans with early-stage prostate cancer. Cancer. 2016 Feb 15; 122(4):626-33.
    View in: PubMed
    Score: 0.110
  14. Reducing PSA-Based Prostate Cancer Screening in Men Aged?75 Years and Older with the Use of Highly Specific Computerized Clinical Decision Support. J Gen Intern Med. 2015 Aug; 30(8):1133-9.
    View in: PubMed
    Score: 0.105
  15. Technology diffusion and diagnostic testing for prostate cancer. J Urol. 2013 Nov; 190(5):1715-20.
    View in: PubMed
    Score: 0.092
  16. Reconsidering the Trade-offs of Prostate Cancer Screening. N Engl J Med. 2020 09 24; 383(13):1289-1290.
    View in: PubMed
    Score: 0.039
  17. Impact of Accountable Care Organizations on Diagnostic Testing for Prostate Cancer. Urology. 2018 06; 116:68-75.
    View in: PubMed
    Score: 0.032
  18. Functional Outcomes Following Nerve Sparing Prostatectomy Augmented with Seminal Vesicle Sparing Compared to Standard Nerve Sparing Prostatectomy: Results from a Randomized Controlled Trial. J Urol. 2017 09; 198(3):600-607.
    View in: PubMed
    Score: 0.030
  19. Sharp Decline In Prostate Cancer Treatment Among Men In The General Population, But Not Among Diagnosed Men. Health Aff (Millwood). 2017 01 01; 36(1):108-115.
    View in: PubMed
    Score: 0.030
  20. Standardizing the definition of adverse pathology for lower risk men undergoing radical prostatectomy. Urol Oncol. 2016 09; 34(9):415.e1-6.
    View in: PubMed
    Score: 0.028
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.